In this study, we directly tested this hypothesis and uncovered a previously unrecognized role for CRMP2 in modulating PTP induction, revealing a potential therapeutic axis for mitochondrial protection in AD. The gene discussed is DPYSL2; the disease is Alzheimer disease.